- Home
- INKT vs TPCS Comparison
INKT vs TPCS Comparison
Compare INKT & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- TPCS
- Stock Information
- Founded
- INKT 2017
- TPCS 1956
- Country
- INKT United States
- TPCS United States
- Employees
- INKT N/A
- TPCS N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- TPCS Metal Fabrications
- Sector
- INKT Health Care
- TPCS Industrials
- Exchange
- INKT Nasdaq
- TPCS Nasdaq
- Market Cap
- INKT 43.0M
- TPCS 31.5M
- IPO Year
- INKT 2021
- TPCS N/A
- Fundamental
- Price
- INKT $11.00
- TPCS $3.19
- Analyst Decision
- INKT Strong Buy
- TPCS
- Analyst Count
- INKT 2
- TPCS 0
- Target Price
- INKT $6.50
- TPCS N/A
- AVG Volume (30 Days)
- INKT 71.4K
- TPCS 22.8K
- Earning Date
- INKT 03-20-2025
- TPCS 01-21-2025
- Dividend Yield
- INKT N/A
- TPCS N/A
- EPS Growth
- INKT N/A
- TPCS N/A
- EPS
- INKT N/A
- TPCS N/A
- Revenue
- INKT N/A
- TPCS $33,182,059.00
- Revenue This Year
- INKT N/A
- TPCS N/A
- Revenue Next Year
- INKT N/A
- TPCS N/A
- P/E Ratio
- INKT N/A
- TPCS N/A
- Revenue Growth
- INKT N/A
- TPCS 6.44
- 52 Week Low
- INKT $4.56
- TPCS $2.85
- 52 Week High
- INKT $19.00
- TPCS $5.95
- Technical
- Relative Strength Index (RSI)
- INKT 59.75
- TPCS 43.57
- Support Level
- INKT $7.32
- TPCS $3.09
- Resistance Level
- INKT $13.79
- TPCS $3.25
- Average True Range (ATR)
- INKT 2.07
- TPCS 0.13
- MACD
- INKT 0.28
- TPCS 0.01
- Stochastic Oscillator
- INKT 71.94
- TPCS 26.67
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.